DailyIQ
Last updated 3 minutes ago

CNC·Centene Corporation

$.
+. (+.%)
After Hours
High
$66.52
Open
$64.07
Market Cap
32.49B
52W High
$69.36
Low
$63.94
P. Close
$65.77
P/E
-
52W Low
$25.08
Fwd P/E
12.54
DailyIQ Est.
-
Technical Score (1D)
73
BUY
News Sentiment
76
BULLISH
CNC has been spotlighted as a leading women‑run company that is redefining growth with discipline and agility, a trend that is resonating with ESG‑focused investors. Because the firm is positioned within this broader narrative of female‑led firms outperforming peers, it may attract additional capital from investors seeking both performance and governance signals. The disciplined growth trajectory that has earned CNC this recognition could translate into stronger earnings momentum over the next 1–10 trading days if the company maintains its current execution pace. This potential upside is contingent on the company’s ability to sustain its disciplined approach amid competitive pressures and macro‑economic uncertainty. Investors should watch for the next earnings release to confirm whether the disciplined growth narrative holds up against actual results. Additionally, any changes in leadership or strategic initiatives could alter the company’s ESG profile and influence investor sentiment. Monitoring regulatory developments that affect ESG reporting standards will also be important, as they could impact how CNC’s governance practices are evaluated. Finally, keeping an eye on broader market flows into women‑led and ESG‑heavy sectors will help gauge whether the current spotlight on CNC is part of a wider trend or a temporary anomaly.
Earnings Summary
Centene Corporation is a healthcare services provider focused on delivering care to government-sponsored and commercially insured individuals across the United States, operating through Medicaid, Medicare, Commercial, and Other segments that include behavioral health and pharmacy benefits. In the last two quarters, Centene posted EPS of $3.37 in Q1 2026 and $2.51 in Q2 2026, both well above estimates of $2.13 and $1.08 respectively, while revenue climbed to $49.94 billion and $53.58 billion, beating guidance of $47.55 billion and $48.09 billion; compared with the prior two quarters, EPS rose from $0.50 in Q3 2025 to $3.37 in Q1 2026 and revenue increased from $49.69 billion in Q3 2025 to $53.58 billion in Q2 2026, indicating a clear acceleration in earnings and top‑line growth. Historically, Centene has shown a consistent upward trajectory, with revenue growing from $40.81 billion in Q4 2024 to $53.58 billion in Q2 2026 and EPS moving from $0.80 in Q4 2024 to $3.37 in Q1 2026, and the company has beaten analyst estimates in every quarter reported, underscoring a pattern of strong margin recovery and cost‑control success. Recent news highlights a Q2 2026 earnings beat that prompted the firm to raise its full‑year 2026 revenue and earnings guidance and redeem $500 million of 2027 notes, signaling confidence in Medicaid margin recovery and managed‑care profitability; analysts have lifted price targets in response, and the company’s focus on expanding its managed‑care network and cost‑saving initiatives is expected to sustain margin gains. Investors should watch for the next earnings release to confirm the durability of cost‑control measures, the trajectory of Medicaid reimbursement rates, and any updates on managed‑care network expansion, as these factors will determine whether the recent margin rebound continues.

EPS

EstBeatMiss
$-1.93$-0.43$1.07$2.56$4.06Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$0.10 - -
Q2'26$1.08$2.51+132.6%
Q1'26$2.13$3.37+57.9%
Q4'25$-1.24$-1.19+3.7%
Q3'25$-0.16$0.50+404.3%
Q2'25$0.21$-0.16-177.3%

Revenue

EstBeatMiss
$46.6B$48.6B$50.6B$52.5B$54.5BQ2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$47.6B - -
Q2'26$48.1B$53.6B+11.4%
Q1'26$47.6B$49.9B+5.0%
Q4'25$48.9B$49.7B+1.7%
Q3'25 - $49.7B -
Q2'25 - $48.7B -

Market Data

CNC Stock Snapshot

CNC is currently trading at $65.84, giving Centene Corporation a market cap of 32.49B. Today's range spans $63.94–$66.52, with shares opening at $64.07 and moving up $0.07 (0.1%) from the prior close. DailyIQ's technical score sits at 73/100 (BUY) with a news sentiment reading of 76/100.

Over the past year CNC has traded between $25.08 and $69.36 - the current price is +162.5% off the 52-week low and -5.1% from the high.

What CNC has right now - BUY signal, 73/100 technical score, bullish sentiment at 76/100, price $65.84 (near 52-week highs) - is the profile that shows up in screens looking for Healthcare growth stories with technical confirmation. At 32.49B in capitalization, the risk/reward of a setup like this is often better than in mega-cap peers where the same signal translates to a smaller percentage move. Range: $25.08–$69.36.

Earnings revision cycles in large-cap Healthcare names tend to compound: when technicals confirm a BUY thesis (73/100) and news sentiment (76/100, bullish) supports the narrative, analyst upgrades follow price rather than lead it. At $65.84 (near 52-week highs), CNC's position within the $25.08–$69.36 annual range suggests there's room for multiple expansion before the stock encounters meaningful technical resistance.

Last updated: August 8, 2026

Company Insights: Centene Corporation (CNC)

Centene Corporation (CNC) operates as a significant player in the Healthcare Plans industry, focusing on government-sponsored and commercially insured individuals across the United States. The company's business model centers on managing health benefits through its Medicaid, Medicare, Commercial, and Other segments, aiming to provide comprehensive care to a broad and often underserved population. Its strategy leverages a network of healthcare providers to deliver essential medical, behavioral, and pharmacy services, addressing diverse healthcare needs.

Recent financial performance indicates a mixed operational picture for Centene. While the company has demonstrated consistent revenue growth, notably from $40.8 billion in Q4 2024 to $49.7 billion in Q4 2025, earnings per share (EPS) have shown considerable volatility. Several quarters have seen significant beats against EPS estimates, such as Q3 2025 and Q1 2025, alongside revenue beats, but other periods, like Q2 2025, experienced EPS misses.

Despite revenue expansion, Centene faces challenges related to profitability, with indications of margin compression over the past five years. The company is actively investing in community initiatives, focusing on social determinants of health and housing through its subsidiaries, which may impact short-term profitability but are intended to improve long-term health outcomes and reduce costs. This strategic focus on value-based care and community engagement is a key element of its forward-looking strategy.

Investor sentiment appears to be cautiously optimistic, with recent reports highlighting increased stakes from institutional investors. This suggests a belief in Centene's long-term potential, possibly driven by its market position in government-sponsored healthcare and its strategic investments. However, sustained customer growth and a clear path to improved profit margins remain critical factors for future performance.

Market Reach

Centene serves a broad demographic, including government-sponsored and commercially insured individuals across the US.

Its core segments of Medicaid and Medicare position it as a key provider for vulnerable populations.

The company's extensive network of providers facilitates comprehensive healthcare delivery.

Revenue Growth

Centene has shown consistent top-line growth, with revenues increasing year-over-year.

Revenue performance has generally met or exceeded analyst expectations in recent quarters.

This growth reflects expanding market penetration and contract wins within its key segments.

Profitability Pressures

Despite revenue increases, EPS has been volatile, with some quarters missing estimates.

There are indications of declining profitability on incremental sales over the last five years.

Margin compression presents a key challenge requiring operational efficiency improvements.

Strategic Investments

Centene is making significant community investments in social determinants of health.

These initiatives aim to improve long-term health outcomes and reduce healthcare costs.

The success of these investments will be crucial for future cost management and value proposition.

Investor Interest

Institutional investors have recently increased their stakes in Centene.

This suggests growing confidence in the company's strategic direction and market position.

However, sustained customer growth and margin improvement are key to validating this interest.

Positioning CNC

Centene Corporation's stock may appeal to investors seeking exposure to the government-sponsored healthcare market. Consider adding to positions on evidence of sustained customer growth and improving profit margins. Reducing exposure could be warranted if profitability challenges persist or if competitive pressures intensify within the Medicaid and Medicare segments.

Risk Factors

Centene Corporation faces risks primarily tied to government program changes, operational execution, and competitive pressures within the healthcare insurance landscape.

  • Medicaid Risk

    Centene's significant reliance on Medicaid contracts exposes it to changes in government policy and reimbursement rates. Reductions in funding or program eligibility could directly impact revenue and profitability. These changes could materialize with new legislative sessions or budget reviews.

  • Margin Compression

    The company has shown indications of declining profitability on incremental sales over the last five years. This suggests increasing costs or pricing pressures that erode margins. If this trend continues, earnings will suffer even with revenue growth.

  • Customer Growth

    Centene has experienced underwhelming customer growth over the past two years. A failure to attract and retain members, especially in competitive markets, will limit future revenue expansion. This risk is ongoing and depends on market dynamics and Centene's value proposition.

  • Integration Risk

    As a large acquirer and operator of various health plans, Centene faces risks in effectively integrating new acquisitions and managing its diverse operations. Poor integration can lead to inefficiencies, higher costs, and failure to realize expected synergies. This risk is present whenever the company pursues M&A activity.

  • Regulatory Scrutiny

    Healthcare providers, particularly those managing government programs, are subject to intense regulatory oversight. Changes in compliance requirements or penalties for non-compliance could lead to significant financial and operational disruptions. This risk is ever-present in the highly regulated healthcare sector.

CNC Competitive Positioning

Centene Corporation (CNC) is tracked alongside these names in Healthcare Plans on DailyIQ.

  • A — Agilent Technologies, Inc.

  • ABBV — AbbVie Inc.

  • ABCL — AbCellera Biologics Inc.

  • ABT — Abbott Laboratories

  • ALGN — Align Technology, Inc.

CNC Recent Earnings History

  • Q4 2025

    EPS: $-1.19 actual vs $-1.24 estimate (beat) · Revenue: $49,725M actual vs $48,870M estimate

  • Q3 2025

    EPS: $0.5 actual vs $-0.16 estimate (beat) · Revenue: $49,690M actual

  • Q2 2025

    EPS: $-0.16 actual vs $0.21 estimate (miss) · Revenue: $48,742M actual

  • Q1 2025

    EPS: $2.9 actual vs $2.52 estimate (beat) · Revenue: $46,620M actual

  • Q4 2024

    EPS: $0.8 actual vs $0.49 estimate (beat) · Revenue: $40,805M actual

Key Metrics for CNC

Centene's performance hinges on its ability to manage government contracts and expand its member base effectively. Key metrics will reveal its operational efficiency and growth trajectory in the competitive health insurance landscape.

Membership Growth: Measures the net change in the number of individuals enrolled in Centene's health plans. Consistent positive growth indicates successful contract wins and retention; declining membership signals competitive pressure or contract losses. This is vital for CNC as higher membership drives premium revenue and scale.

Medical Loss Ratio: Represents the percentage of premiums spent on medical claims and quality improvements. A lower MLR generally suggests better profitability for Centene; a rising MLR can indicate increasing healthcare costs or pricing pressures. This metric is critical for assessing CNC's underwriting profitability.

Adjusted EBITDA: Reflects Centene's operational profitability before interest, taxes, depreciation, and amortization. Increasing Adjusted EBITDA demonstrates improved operational efficiency and earnings power; a decline suggests challenges in managing costs or revenue. This is a key indicator of CNC's ability to generate cash from its core operations.

Government Contract Wins: Tracks Centene's success in securing and retaining contracts with government entities (Medicaid, Medicare). Significant wins are essential for future revenue growth; losses can severely impact top-line performance. This metric directly impacts CNC's long-term growth prospects and market share.

Days Sales Outstanding: Measures the average number of days it takes for Centene to collect payment after a sale. A decreasing DSO indicates efficient cash collection; a rising DSO can signal potential collection issues or working capital strain. This is important for CNC's cash flow management and operational liquidity.

What Moves CNC Stock?

Centene Corporation's stock performance is primarily driven by the dynamics of government-sponsored healthcare programs and the company's ability to manage profitability within these complex markets.

Medicaid/Medicare Growth

Centene's core business relies heavily on contracts with state and federal governments for Medicaid and Medicare programs. Growth in membership within these government-backed health plans directly translates to increased revenue potential.

Expansion in these segments, particularly through new contract wins or favorable policy changes, tends to boost investor confidence and drive the stock price upward. Conversely, any contraction in membership or loss of key contracts can pressure the stock.

Profitability Trends

Despite revenue growth, Centene has faced challenges with consistent profitability, as indicated by fluctuating EPS and reports of declining profitability on incremental sales. Managing medical costs and operational efficiency are critical factors.

Improvements in profit margins and consistent earnings beats, as seen in some past quarters, can lead to significant stock appreciation. Conversely, earnings misses and margin compression often result in stock price declines, reflecting investor concerns about operational execution.

Community Investments

Centene is making substantial investments in social determinants of health and community initiatives through its subsidiaries. These efforts aim to improve long-term health outcomes and potentially reduce future healthcare costs.

While these investments may not immediately impact short-term earnings, they are viewed by some investors as strategic for future growth and regulatory compliance. Positive developments or clear ROI from these initiatives could support the stock, while concerns about their financial impact might weigh on it.

Key insight: Centene's stock hinges on its ability to expand its government-sponsored health plan membership while simultaneously demonstrating consistent profit margin improvement. Investor focus remains on operational execution and the long-term impact of its strategic community investments.

Analyst Price Targets for CNC

The current spread of analyst price targets and ratings for Centene Corporation (CNC).

Consensus Target
$44.18
High Target
$70.0
Low Target
$32.0
Buy / Hold / Sell
8 / 16 / 2

Reflects the most recently tracked analyst ratings for CNC and may lag real-time updates. Not a recommendation to buy or sell.

Frequently Asked Questions About CNC

What is Centene Corporation (CNC) stock's investment thesis?

The investment thesis for Centene Corporation (CNC) centers on its role as a major provider of government-sponsored healthcare plans, particularly Medicaid and Medicare. Its ability to serve a broad and often underserved population, coupled with strategic community investments aimed at improving long-term health outcomes, forms a core part of its value proposition. Investors may consider its scale and reach within the managed care landscape.

What drives Centene Corporation (CNC) stock price?

Centene Corporation's stock price is primarily influenced by government healthcare policy changes, regulatory environments, and contract wins or losses with state and federal programs. Fluctuations in membership numbers, healthcare utilization rates, and the company's ability to manage costs effectively also play a significant role. Investor sentiment regarding the profitability and growth prospects of its Medicaid and Medicare segments can also impact CNC's stock performance.

Does Centene Corporation (CNC) pay a dividend?

Centene Corporation (CNC) does not currently pay a dividend to its shareholders. The company has historically focused on reinvesting its earnings back into the business for growth initiatives, acquisitions, and operational improvements. Investors seeking income through dividends would need to consider other companies in the healthcare sector that offer such payouts.

What are the risks of investing in Centene Corporation (CNC) stock?

Key risks for Centene Corporation (CNC) include regulatory and policy changes affecting government healthcare programs, increased competition within the managed care industry, and challenges in managing healthcare costs and medical loss ratios. Operational execution, cybersecurity threats, and the company's ability to effectively integrate acquisitions also present potential headwinds. Furthermore, fluctuations in membership and reimbursement rates can impact financial performance.

How is Centene Corporation (CNC) performing financially?

Centene Corporation (CNC) has shown revenue growth in recent quarters, with revenues increasing year-over-year. However, earnings per share have been inconsistent, with some periods showing beats against estimates and others showing misses. While revenue trends are positive, there are indications of margin compression over the past five years, suggesting ongoing efforts to improve profitability on sales.

What is Centene Corporation's (CNC) market position in the healthcare plans industry?

Centene Corporation (CNC) holds a significant market position as a leading provider of government-sponsored healthcare plans in the United States. Its focus on serving Medicaid, Medicare, and commercially insured individuals, particularly those with limited access to care, distinguishes it. The company operates through a vast network of providers, aiming to deliver comprehensive health benefits across various segments.

What are Centene Corporation's (CNC) growth strategies?

Centene Corporation's (CNC) growth strategies often involve expanding its presence in government-sponsored healthcare programs through contract wins and strategic bids. The company also focuses on enhancing its service offerings, investing in technology to improve operational efficiency, and undertaking community investments to address social determinants of health, which can lead to long-term cost savings and improved member outcomes.

How does Centene Corporation (CNC) approach innovation and technology?

Centene Corporation (CNC) leverages technology to manage its vast member base and complex healthcare operations. This includes investments in digital platforms for member engagement, data analytics for population health management, and systems to streamline claims processing and provider networks. Innovation efforts are also directed towards developing new care models and improving the accessibility and quality of healthcare services.

What is Centene Corporation's (CNC) valuation based on current metrics?

Centene Corporation's (CNC) valuation can be assessed through various financial metrics, though a specific P/E ratio is not consistently available. Investors typically examine its market capitalization relative to its revenue and earnings potential, considering its position within the healthcare plans sector. Comparisons with industry peers and an analysis of its growth prospects and profitability trends are crucial for determining its current valuation.

What are Centene Corporation's (CNC) recent news and developments?

Recent news for Centene Corporation (CNC) includes discussions about its stock performance relative to market indices and specific initiatives by its subsidiaries, such as Superior HealthPlan, to improve healthcare access. The company is also noted for its significant community investments aimed at addressing social determinants of health. Investor interest has been observed, with some institutional investors increasing their stakes.

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

0+ articles